Endocrine health in survivors of adult-onset cancer

Publikation: Beitrag in FachzeitschriftÜbersichtsartikel (Review)BeigetragenBegutachtung

Beitragende

  • Cornelia S Link-Rachner - , Medizinische Klinik und Poliklinik I, Klinik und Poliklinik für Kinder- und Jugendmedizin (Autor:in)
  • Andy Göbel - , Medizinische Klinik und Poliklinik III, Mildred Scheel Early Career Center, Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany; Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany. (Autor:in)
  • Nikolai P Jaschke - , Medizinische Klinik und Poliklinik III, Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; German Cancer Consortium (DKTK), partner site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA. (Autor:in)
  • Tilman D Rachner - , Medizinische Klinik und Poliklinik III, Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; German Cancer Consortium (DKTK), partner site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: tilman.rachner@uniklinikum-dresden.de. (Autor:in)

Abstract

Long-term survivors of cancer (ie, the patient who is considered cured or for whom the disease is under long-term control and unlikely to recur) are at an increased risk of developing endocrine complications such as hypothalamic-pituitary dysfunctions, hypogonadisms, osteoporosis, or metabolic disorders, particularly when intensive tumour-directed therapies are applied. Symptom severity associated with these conditions ranges from mild and subclinical to highly detrimental, affecting individual health and quality of life. Although they are usually manageable, many of these endocrine pathologies remain underdiagnosed and untreated for years. To address this challenge, a higher degree of awareness, standardised screening tools, comprehensible treatment algorithms, and a close collaborative effort between endocrinologists and oncologists are essential to early identify patients who are at risk, and to implement appropriate treatment protocols. This Review highlights common symptoms and conditions related to endocrine disorders among survivors of adult-onset cancer, provides a summary of the currently available practice guidelines, and proposes a practical approach to diagnose affected patients among this group.

Details

OriginalspracheEnglisch
Seiten (von - bis)350-364
Seitenumfang15
FachzeitschriftThe Lancet. Diabetes & endocrinology
Jahrgang12
Ausgabenummer5
PublikationsstatusVeröffentlicht - Mai 2024
Peer-Review-StatusJa

Externe IDs

Scopus 85189813001

Schlagworte

Schlagwörter

  • Humans, Cancer Survivors, Endocrine System Diseases/etiology, Neoplasms/complications, Adult, Age of Onset